Trial Profile
A study to elucidate the effect of application conditions of a percutaneously absorbed type beta-1 blocker in healthy adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Aug 2016
Price :
$35
*
At a glance
- Drugs Bisoprolol (Primary)
- Indications Atrial fibrillation; Heart failure; Hypertension
- Focus Pharmacokinetics
- Sponsors Toa Eiyo
- 13 Aug 2016 Status changed from recruiting to completed.
- 23 Jun 2016 New trial record